Koustav Banerjee
CEO, Alkem Medtech
Notable Quotes
We are already EBITDA positive in the present year and our estimate is to have 10% EBITDA by FY27 which will take us to around 23 to 24% in 3 years time.
CEO, Alkem Medtech
We are already EBITDA positive in the present year and our estimate is to have 10% EBITDA by FY27 which will take us to around 23 to 24% in 3 years time.